| Dr Michael Gurfinkel, DO | |
|
1401 Franklin Ave, Garden City, NY 11530-1613 | |
| (516) 877-2626 | |
| (516) 877-0945 |
| Full Name | Dr Michael Gurfinkel |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 27 Years |
| Location | 1401 Franklin Ave, Garden City, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417936485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 216638 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
Ore Pharmaceutical Holdings Inc., announced today the filing of a Form 15 with the Securities and Exchange Commission (the "SEC"). Ore filed the Form 15 with the SEC in order to effect a termination of the registration of its common stock under the Securities Exchange Act of 1934.
The fixed beam room, or eyeline, at the University of Florida Proton Therapy Institute is up and running and radiation oncologist Robert Malyapa, M.D., Ph.D. completed treating the facility's first eye cancer patient this week.
"The world's first vaccine against dengue fever, being developed by French drugmaker Sanofi SA, protected against three of the virus's four strains in a keenly awaited clinical trial in Thailand," the company announced on Wednesday, Reuters reports.
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis (CF) are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Children's Center.
› Verified 1 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Ore Pharmaceutical Holdings Inc., announced today the filing of a Form 15 with the Securities and Exchange Commission (the "SEC"). Ore filed the Form 15 with the SEC in order to effect a termination of the registration of its common stock under the Securities Exchange Act of 1934.
The fixed beam room, or eyeline, at the University of Florida Proton Therapy Institute is up and running and radiation oncologist Robert Malyapa, M.D., Ph.D. completed treating the facility's first eye cancer patient this week.
"The world's first vaccine against dengue fever, being developed by French drugmaker Sanofi SA, protected against three of the virus's four strains in a keenly awaited clinical trial in Thailand," the company announced on Wednesday, Reuters reports.
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis (CF) are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Children's Center.
› Verified 1 days ago
| Entity Name | Winthrop Community Medical Affiliates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457873077 PECOS PAC ID: 5698092385 Enrollment ID: O20150317001669 |
News Archive
Ore Pharmaceutical Holdings Inc., announced today the filing of a Form 15 with the Securities and Exchange Commission (the "SEC"). Ore filed the Form 15 with the SEC in order to effect a termination of the registration of its common stock under the Securities Exchange Act of 1934.
The fixed beam room, or eyeline, at the University of Florida Proton Therapy Institute is up and running and radiation oncologist Robert Malyapa, M.D., Ph.D. completed treating the facility's first eye cancer patient this week.
"The world's first vaccine against dengue fever, being developed by French drugmaker Sanofi SA, protected against three of the virus's four strains in a keenly awaited clinical trial in Thailand," the company announced on Wednesday, Reuters reports.
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis (CF) are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Children's Center.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Gurfinkel, DO 1401 Franklin Ave, Garden City, NY 11530-1613 Ph: (516) 877-2626 | Dr Michael Gurfinkel, DO 1401 Franklin Ave, Garden City, NY 11530-1613 Ph: (516) 877-2626 |
News Archive
Ore Pharmaceutical Holdings Inc., announced today the filing of a Form 15 with the Securities and Exchange Commission (the "SEC"). Ore filed the Form 15 with the SEC in order to effect a termination of the registration of its common stock under the Securities Exchange Act of 1934.
The fixed beam room, or eyeline, at the University of Florida Proton Therapy Institute is up and running and radiation oncologist Robert Malyapa, M.D., Ph.D. completed treating the facility's first eye cancer patient this week.
"The world's first vaccine against dengue fever, being developed by French drugmaker Sanofi SA, protected against three of the virus's four strains in a keenly awaited clinical trial in Thailand," the company announced on Wednesday, Reuters reports.
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis (CF) are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Children's Center.
› Verified 1 days ago
Dr. Daniel S Donohue, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 975 Stewart Ave, Garden City, NY 11530 Phone: 516-222-8650 Fax: 516-745-5476 | |
Jung H Youn, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Franklin Ave, Suite 300, Garden City, NY 11530 Phone: 516-248-6868 Fax: 516-248-6841 | |
Dr. Miguel Cima, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 877 Stewart Ave, Suite 28, Garden City, NY 11530 Phone: 516-222-1000 Fax: 516-222-1017 | |
Dr. Philip Stein, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 975 Stewart Ave, Garden City, NY 11530 Phone: 516-222-8630 Fax: 516-745-5476 | |
Dr. Kinga Marta Riccobono, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 Franklin Ave, Suite 106, Garden City, NY 11530 Phone: 516-240-8700 Fax: 516-240-8787 | |
Dr. Robert J Bonasera, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1205 Franklin Ave Ste 150, Garden City, NY 11530 Phone: 516-222-0067 Fax: 516-222-0071 | |
Dr. Richard Keith Schwartz, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1401 Franklin Ave, Garden City, NY 11530 Phone: 516-877-2626 Fax: 516-877-0945 |